A deeper understanding of the molecular details of a physiologically relevant transporter protein, such as ABCG1, may contribute to the identification of new drug targets for diseases associated with this transporter, such as atherosclerosis, obesity, adipocyte lipid storage, type 2 diabetes, and age-related macular degeneration. This evidence concerns the gene ABCG1 and Obesity.